ABBOTT BIOTECH INC has a total of 11 patent applications. Its first patent ever was published in 1989. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are SHENZHEN IN VIVO BIOMEDICINE TECH LIMITED COMPANY, CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORG SPEYER HAUS and B MOGEN BIOTECHNOLOGIES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Australia | 1 | |
#5 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Foods and drinks | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Microorganisms | |
#3 | Medical preparations | |
#4 | Therapeutic chemical compounds | |
#5 | Enzymes | |
#6 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Gillies Stephen D | 8 |
#2 | Magee Andrew S | 2 |
#3 | Shyr Ann W | 2 |
#4 | Tsang Wen-Ghih | 2 |
#5 | Foley Susan F | 1 |
#6 | Lo Kin-Ming | 1 |
#7 | Edmunds Timothy | 1 |
Publication | Filing date | Title |
---|---|---|
US5196320A | Method of producing engineered binding proteins | |
AU7333491A | Antibody constructs with enhanced binding affinity | |
US5149635A | Messenger RNA stabilization in animal cells | |
EP0457837A1 | Stabilization of aqueous-based hydrophobic protein solutions and sustained release vehicle |